Skip to main content
Vencanna Ventures logo

Vencanna Ventures — Investor Relations & Filings

Ticker · VENI ISIN · CA92260V1031 CSE Financial and insurance activities
Open in API
Filings indexed 243 across all filing types
Latest filing 2025-04-01 Earnings Release
Country CA Canada
Listing CSE VENI

About Vencanna Ventures

https://vencanna.com/

Vencanna Ventures operates as a venture capital firm focused on the global cannabis sector, specializing in seed and early-stage initiatives. The firm's core mandate is to provide capital, liquidity, and operational expertise to jurisdictionally compliant cannabis businesses. Vencanna aims to facilitate the consolidation of fragmented markets by supplying acquisition capital. Investment criteria emphasize opportunities that are at or near cash flow positive, require low upfront capital outlays, and demonstrate high potential returns, typically targeting a 3x to 5x return on investment within a two-to-five-year timeframe.

Recent filings

Filing Released Lang Actions
News release (section 4.8 of NI 62-104).pdf
Earnings Release Classification · 90% confidence The document is a press release summarizing the Company’s quarterly financial results for the three months ended January 31, 2025, with selected highlights (revenues, costs, net loss, etc.), a corporate update and NCIB announcement. It explicitly refers to the MD&A and full statements being available elsewhere (SEDAR+), indicating that this is an earnings release (initial announcement of periodical results) rather than the full interim report. Therefore, it fits the Earnings Release category. Q3 2025
2025-04-01 English
News release - English.pdf
Earnings Release Classification · 86% confidence The document is a press release summarizing interim (quarterly) financial results for the three months ended January 31, 2025, providing selected highlights (revenues, profit/loss, assets/liabilities) and brief corporate updates. It clearly announces key quarterly financial metrics and refers readers to the full financial statements and MD&A on SEDAR+. There is no comprehensive full report here, making it an initial Earnings Release (ER) rather than a full Interim/Quarterly Report or other category. Q3 2025
2025-04-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2025-04-01 English
Interim MD&A - English.pdf
Regulatory Filings
2025-04-01 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements For the Periods ended January 31, 2025 and 2024' and contains detailed unaudited interim financial statements including statements of financial position, loss and comprehensive income, changes in shareholders' equity, and cash flows. It references compliance with IAS 34, Interim Financial Reporting, and includes substantive financial data and notes. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of interim financial statements and the period covered (less than a full fiscal year) clearly identifies this as an Interim / Quarterly Report. Therefore, the appropriate classification is 'IR'. 9M 2025
2025-04-01 English
Letter from former auditor.pdf
Regulatory Filings Classification · 70% confidence The document is a letter from MNP LLP to provincial securities commissions in Canada, responding to a "Notice of Change of Auditor" filed under National Instrument 51-102. It is not the audit report itself, nor an annual or interim report, but rather a regulatory notice/filing. It does not fall into any more specific category, so it defaults to the fallback category for miscellaneous regulatory filings (RNS).
2025-02-19 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.